ABOUT THE DRUG
Docetaxel, sold under the brand name Taxotere, is a chemotherapy medication used to treat a number of types of cancer including breast cancer, head and neck cancer, stomach cancer, prostate cancer and non small-cell lung cancer. Taxotere may be used by itself or along with other chemotherapy medication. It is administered through slow injection directly into a patient’s vein.
It has been shown that Taxotere is linked to permanent hair loss in some clients, a disfiguring side effect for people already dealing with the harsh realities of fighting cancer. Other common side effects include low blood cell counts, numbness, shortness of breath, vomiting, and muscle pains. Other severe side effects include allergic reactions and future cancers.
PURPOSE OF THE DRUG
Taxotere is a chemotherapy treatment drug used in the fight against certain cancers such as breast cancer, head and neck cancer, stomach cancer, prostate cancer and non small-cell lung cancer.
An estimated 9% of patients given Taxotere will experience permanent hair loss lasting ten years or more. Sanofi-Aventis failed to warn patients of these disfiguring risks.
HOW BRAMZON LAW FIRM PLLC CAN HELP
Recent successful lawsuits have alleged that Sanofi-Aventis knew of the risks associated with Taxotere usage and its link to permanent hair loss, but purposefully failed to inform consumers. Lawsuits have been filed and a multi-district litigation has been certified by the court, as well as, individual cases in other states.
If you have been diagnosed with permanent hair loss as a result of taking prescription Taxotere, contact us immediately for a no cost case evaluation. You may be entitled to compensation. The irresponsibility on the part of Sanofi-Aventis is egregious, and consumers and their families should understand the risks and how to protect themselves.